Raphael Pharmaceutical (RAPH) Non-Current Assets (2022 - 2025)

Raphael Pharmaceutical has disclosed Non-Current Assets across 4 years of filings, most recently posting $2000.0 for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $2000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $8000.0 (down 11.11% YoY), and the FY2025 annual result was $2000.0, changed 0.0% from the prior year.
• Non-Current Assets came in at $2000.0 for Q4 2025 at Raphael Pharmaceutical, roughly flat from $2000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3000.0 in Q1 2024 to a low of $1000.0 in Q1 2023.
• The 4-year median for Non-Current Assets is $2000.0 (2022), against an average of $1857.1.
• Across the five-year window, Non-Current Assets plunged 50.0% in 2023 and surged 200.0% in 2024, its largest moves.
• Raphael Pharmaceutical's Non-Current Assets stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
• The last three Non-Current Assets figures came in at $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.